Beverly S. Mitchell, M.D.
Academic Appointments
- Professor, Medicine - Oncology
- Member, Stanford Cancer Institute
- Professor, Medicine - Hematology
- Professor (By courtesy), Chemical and Systems Biology
Key Documents
Contact Information
-
Clinical Offices
Stanford Clinical Cancer Center 875 Blake Wilbur Drive Stanford, CA 94305 Tel Work (650) 725-9621 Fax (650) 736-0607
- Academic Offices
Personal Information Email Tel (650) 736-7716Alternate Contact Natalie Huen Administrative Assistant Email Tel Work 650.736.7716Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Hematology
- Cancer> Hematology> Hematologic Malignancies
- Cancer> Lymphoma
- Hematology
Administrative Appointments
- Director, Stanford Cancer Institute (2008 - present)
- Deputy Director, Stanford Cancer Center (2005 - 2008)
Honors and Awards
- President, American Society of Hematology (2001)
- Member, American Society for Clinical Investigation (to present)
- Member, Association of American Professors (1991)
- Stohlman Award, Leukemia Society of America (1988)
- National Academy of Sciences, Institute of Medicine (Inducted 2001)
Professional Education
| Medical Education: | Harvard Medical School MA (1969) |
| Board Certification: | Hematology, American Board of Internal Medicine (1978) |
| Fellowship: | University Hospital Zurich, Switzerland (1973) |
| Fellowship: | University of Michigan Hospital MI (1977) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1973) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Beverly S. Mitchell, MD, is the Director of the Stanford Cancer Institute and is the George E. Becker Professor of Medicine at Stanford University. Before joining the Stanford faculty, Dr. Mitchell lead the Molecular Therapeutics Program at UNC Chapel Hill's Lineberger Comprehensive Cancer Center, where she also served as Associate Director for Translational Research and Chief of the Division of Hematology/Oncology.
Dr. Mitchell received a bachelors degree in biochemistry from Smith College in Massachusetts and received her MD from Harvard Medical School. She completed her medical training as Chief Resident at the University of Washington. After completing a research fellowship at the Metabolic Laboratory at the University of Zurich in Switzerland she was awarded a Hematology Fellowship at the University of Michigan. Dr. Mitchell was a faculty member in the Departments of Medicine and Pharmacology at the University of Michigan for 16 years before moving to UNC.
Dr. Mitchell has authored over 130 peer-reviewed articles. She served as President of the American Society of Hematology (ASH) and was Chair of the Medical and Scientific Affairs Committee and Vice Chair for Medical and Scientific Affairs of the Leukemia and Lymphoma Society of America.
Dr. Mitchell's research relates to the development of new therapies for hematologic malignancies. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.
Publications
- Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53. Mol Pharmacol. 2011; (1): 40-8
- Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells. Leukemia. 2011
- Reactive oxygen species regulate nucleostemin oligomerization and protein degradation. J Biol Chem. 2011; (13): 11035-46
- Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin. Cancer Res. 2009; (7): 3004-12
- Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H. Leuk Res. 2008; (8): 1268-78
